Location: Stockholm, Sweden
CIK: 0001381843 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Jan 18, 2022
Total Value: $70.97M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IRWD | IRONWOOD PHARMACEUTICALS INC | 730,000 | $8.512M | 12.0% | $10.90 | +12.5% | COM CL A | 46333X108 |
| MCK | MCKESSON CORP | 34,000 | $8.451M | 11.9% | $203.36 | +5.6% | COM | 58155Q103 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 195,000 | $8.315M | 11.7% | $32.59 | +22.3% | COM | 413197104 |
| ABBV | ABBVIE INC | 48,000 | $6.499M | 9.2% | $95.52 | +6.5% | COM | 00287Y109 |
| CAH | CARDINAL HEALTH INC | 125,000 | $6.436M | 9.1% | $45.64 | -2.2% | COM | 14149Y108 |
| COR | AMERISOURCEBERGEN CORP | 48,000 | $6.379M | 9.0% | $115.73 | +1.2% | COM | 03073E105 |
| BMY | BRISTOL-MYERS SQUIBB CO | 100,000 | $6.235M | 8.8% | $49.60 | -0.7% | COM | 110122108 |
| UTMD | UTAH MED PRODS INC | 40,000 | $4M | 5.6% | $88.34 | +15.5% | COM | 917488108 |
| — | LA JOLLA PHARMACEUTICAL CO | 830,000 | $3.86M | 5.4% | $4.44 | — | COM | 503459604 |
| — | LANNET INC | 2,000,000 | $3.24M | 4.6% | $2.84 | — | COM | 516012101 |
| — | ZOGENIX INC | 195,000 | $3.169M | 4.5% | $15.19 | — | COM NEW | 98978L204 |
| — | INTERCEPT PHARMACEUTICALS IN | 183,000 | $2.981M | 4.2% | $16.29 | — | COM | 45845P108 |
| — | RIGEL PHARMACEUTICALS INC | 1,090,000 | $2.889M | 4.1% | $3.63 | — | COM NEW | 766559603 |